Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2025-12-19 00:00:00 ET · period of report 2025-12-18 · accession 0001171843-25-008039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | 2025-12-18 | BCRX | Stonehouse Jon P | CEO, Dir | G - Gift | $0.00 | -20.0K | 1.39M | -1% | $0 | |
| MI | 2025-12-19 | 2025-12-18 | BCRX | Stonehouse Jon P | CEO, Dir | G - Gift | $0.00 | +20.0K | 40.0K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-18 | G | D | 20,000 | $0.00 | 1,385,222 | D By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust | — | — | |
| 2 | Common | Common Stock | 2025-12-18 | G | A | 10,000 | $0.00 | 40,000 | I By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust | — | — | |
| 3 | Common | Common Stock | 2025-12-18 | G | A | 10,000 | $0.00 | 40,000 | I | — | — |